|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-3
|
|
pubmed:abstractText |
Aim of the study was to quantify ERCC1, RRM1, and TopoIIalpha mRNA expression profile as predictive factors for response and survival in SCLC patients treated with platinum/etoposide.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/DNA topoisomerase II alpha,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ERCC1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Endonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Platinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:BacilloElisaE,
pubmed-author:CalogeroRaffaeleR,
pubmed-author:CappiaSusannaS,
pubmed-author:CeppiPaoloP,
pubmed-author:LongoMarinaM,
pubmed-author:NovelloSilviaS,
pubmed-author:PapottiMauroM,
pubmed-author:SaviozziSilviaS,
pubmed-author:ScagliottiGiorgio VGV,
pubmed-author:SelvaggiGiovanniG,
pubmed-author:VolanteMarcoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
583-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18520795-Adult,
pubmed-meshheading:18520795-Aged,
pubmed-meshheading:18520795-Aged, 80 and over,
pubmed-meshheading:18520795-Antigens, Neoplasm,
pubmed-meshheading:18520795-Antineoplastic Agents,
pubmed-meshheading:18520795-Carboplatin,
pubmed-meshheading:18520795-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18520795-Cisplatin,
pubmed-meshheading:18520795-DNA, Neoplasm,
pubmed-meshheading:18520795-DNA Repair,
pubmed-meshheading:18520795-DNA Topoisomerases, Type II,
pubmed-meshheading:18520795-DNA-Binding Proteins,
pubmed-meshheading:18520795-Endonucleases,
pubmed-meshheading:18520795-Etoposide,
pubmed-meshheading:18520795-Female,
pubmed-meshheading:18520795-Follow-Up Studies,
pubmed-meshheading:18520795-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18520795-Humans,
pubmed-meshheading:18520795-Isoenzymes,
pubmed-meshheading:18520795-Italy,
pubmed-meshheading:18520795-Lung Neoplasms,
pubmed-meshheading:18520795-Male,
pubmed-meshheading:18520795-Middle Aged,
pubmed-meshheading:18520795-Platinum Compounds,
pubmed-meshheading:18520795-Polymerase Chain Reaction,
pubmed-meshheading:18520795-Prognosis,
pubmed-meshheading:18520795-Retrospective Studies,
pubmed-meshheading:18520795-Severity of Illness Index,
pubmed-meshheading:18520795-Survival Rate,
pubmed-meshheading:18520795-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
|
|
pubmed:affiliation |
Thoracic Oncology Unit, University of Torino, S. Luigi Hospital, Orbassano (Torino), Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
